Focus Partners Wealth
GOSS icon

Focus Partners Wealth’s Gossamer Bio GOSS Stock Holding History

Focus Partners Wealth’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Buy
1,161
+248
+27% +$5.54K ﹤0.01% 2746
2026
Q1 		$24K Buy
+913
New +$115K ﹤0.01% 2607
2025
Q4 		– Sell
-16,565
Closed -$3.49M – 2738
2025
Q3 		$3.49M Buy
16,565
+2,190
+15% +$386K 0.01% 858
2025
Q2 		$1.41M Buy
14,375
+5,625
+64% +$491K ﹤0.01% 1008
2025
Q1 		$770K Buy
+8,750
New +$809K ﹤0.01% 1163

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Focus Partners Wealth's GOSS Position: Q2 2026 in Review

Focus Partners Wealth increased its Gossamer Bio (GOSS) stake by 27% in Q2 2026, buying an estimated $5.54K and bringing the position to 1,161 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

Focus Partners Wealth first reported a position in GOSS in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.49M in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Focus Partners Wealth held 1,161 shares of Gossamer Bio worth $15.3K as of Q2 2026.
  • Focus Partners Wealth bought 248 Gossamer Bio shares in Q2 2026, an estimated $5.54K.
  • Gossamer Bio made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2746 holding.
  • Focus Partners Wealth first reported a position in Gossamer Bio in Q1 2025 and has held it in 5 quarters since.
  • Focus Partners Wealth's Gossamer Bio position peaked at $3.49M in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.